Neonatal hypoglycaemia: learning from claims.

Area of Science:

• Neonatal Medicine
• Healthcare Litigation
• Patient Safety

Background:

• Neonatal hypoglycemia is a significant cause of infant morbidity and potential long-term neurodevelopmental harm.
• Litigation claims related to neonatal hypoglycemia represent a considerable financial burden on the National Health Service (NHS).

Purpose of the Study:

• To identify common pitfalls in the management of neonatal hypoglycemia by analyzing litigation claims.
• To improve patient safety and reduce harm through targeted clinical awareness and training.

Main Methods:

• A review of 30 anonymized claims submitted to the NHS Litigation Authority (NHS LA) between 2002 and 2011.
• Analysis focused on risk factors, clinical signs, care deficits, and financial costs associated with neonatal hypoglycemia claims.

Main Results:

• Claims involved infants of at least 36 weeks gestation; common risk factors included low birth weight.
• Abnormal feeding behavior was the most frequently reported presenting sign of hypoglycemia.
• Avoidable deficits in care were identified in all reviewed cases, with 25 claims resulting in £16,216,677 in damages paid.

Conclusions:

• Clinical themes from severe neonatal hypoglycemia cases should inform training and guidance.
• Improving care based on these insights can reduce harm and reallocate litigation funds to direct patient care.